Amneal Pharmaceuticals, Inc.
(NYSE : AMRX)

( )
AMRX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co. 0.30%66.981.0%$730.28m
JNJJohnson & Johnson -0.01%148.220.7%$717.99m
PFEPfizer Inc. 0.25%40.700.9%$622.86m
MRKMerck & Co., Inc. -0.12%91.070.7%$584.04m
ABBVAbbVie, Inc. 0.32%89.552.3%$541.23m
LLYEli Lilly & Co. 0.21%141.411.1%$422.89m
APLSApellis Pharmaceuticals, Inc. -3.99%40.380.0%$108.01m
AZNAstraZeneca Plc 2.52%51.771.2%$100.94m
NVSNovartis AG 0.55%95.120.2%$98.83m
GSKGlaxoSmithKline Plc 2.20%48.190.2%$82.87m
SNYSanofi 0.25%51.320.2%$75.57m
NVONovo Nordisk A/S 0.54%61.620.1%$67.44m
RETAReata Pharmaceuticals, Inc. 1.80%216.273.5%$67.01m
KRTXKaruna Therapeutics, Inc. -0.43%95.330.0%$59.01m
TPTXTurning Point Therapeutics, Inc. 8.38%58.360.0%$41.00m

Company Profile

Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.